Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
Netcapital Inc. received an extension from Nasdaq to regain compliance with Listing Rule 5250(c)(1) regarding delinquent periodic reports. The company has been granted until February 9, 2027, to file its Form 10-K for the fiscal year ended April 30, 2026, and its Form 10-Q for the quarter ended July 31, 2026. Failure to meet this deadline will result in a delisting notification, which the company may then appeal.
Knightscope received a deficiency notice from Nasdaq because its Class A Common Stock closed below the $1.00 minimum bid price for 30 consecutive business days. The company has 180 calendar days, until May 3, 2027, to regain compliance by maintaining a bid price of at least $1.00 for ten consecutive business days. The notice does not result in immediate delisting, and the stock continues to trade under the symbol 'KSCP'.
Curis, Inc. received a delisting determination letter from Nasdaq on November 2, 2026, because its common stock closed below the $1.00 minimum bid price for 30 consecutive business days. Due to a previous 1-for-20 reverse stock split in July 2026 and an existing Panel Monitor, the company is not eligible for a standard compliance period and faces immediate delisting risk. The company intends to appeal the decision to a Nasdaq Hearings Panel to stay the delisting process.
Fifth Era Acquisition Corp I Nasdaq/NYSE Compliance Notice
Fifth Era Acquisition Corp I received an extension from Nasdaq to regain compliance with the minimum 400 total holders requirement for continued listing on the Nasdaq Global Market. The company has until March 15, 2027, to demonstrate compliance or face potential delisting of its Class A ordinary shares, units, and rights.
Barfresh Food Group Inc. received a deficiency notice from Nasdaq on November 5, 2026, for failing to maintain a minimum closing bid price of $1.00 per share for 30 consecutive business days. The company has until May 4, 2027, to regain compliance, which requires the stock to close at $1.00 or higher for at least 10 consecutive business days. Additionally, the company is currently under a separate compliance period until February 1, 2027, to meet the $35 million minimum market value of listed securities requirement.
Tempest Therapeutics received a deficiency notice from Nasdaq on November 4, 2026, because its common stock failed to maintain a minimum bid price of $1.00 for 30 consecutive business days. The company has until May 3, 2027, to regain compliance by maintaining a closing bid price of at least $1.00 for 10 consecutive business days. The notice has no immediate effect on the listing of the company's common stock.
Pantages Capital Acquisition Nasdaq/NYSE Compliance Notice
Pantages Capital Acquisition Corporation received an extension from Nasdaq to regain compliance with the Minimum Total Holders Requirement. The company has until March 1, 2027, to demonstrate it has at least 400 total holders of its Class A ordinary shares to avoid delisting.
Sports Entertainment Gaming Global Nasdaq/NYSE Compliance Notice
Sports Entertainment Gaming Global Corporation has regained compliance with Nasdaq Listing Rule 5250(c)(1) after filing its delinquent Quarterly Report on Form 10-Q for the period ended June 30, 2026. As a result, the previously scheduled hearing before the Nasdaq Hearings Panel has been cancelled, and the company's common stock will continue to be listed and traded on The Nasdaq Global Market.
Local Bounti Corporation received a nine-month extension from the NYSE to regain compliance with the minimum market capitalization and stockholders' equity standards. The company now has until August 5, 2027, to achieve a 30-day average market capitalization or stockholders' equity of at least $50 million.
Cognition Therapeutics received a deficiency notice from Nasdaq on November 3, 2026, because its common stock failed to maintain a minimum closing bid price of $1.00 per share for 30 consecutive business days. The company has until May 3, 2027, to regain compliance by having its stock price close at or above $1.00 for at least 10 consecutive business days.
Counterparty
Nasdaq
Term
180 days
“The work we conducted with the Office of Neuroscience at the FDA during 2026 culminated in the development of a trial protocol for a planned registrational study of zervimesine (CT1812) in people with dementia with Lewy bodies (DLB). We are now evaluating our plans for manufacturing, site selection, and patient recruitment.”
Lisa Ricciardi, Cognition’s president and CEO
“At the same time, we are working with our collaborators at the Alzheimer’s Clinical Trial Consortium (ACTC) to prepare for the conclusion of the Phase 2 START Study in people with MCI and early Alzheimer’s disease. Top-line results from START are anticipated in the second half of 2027 and will inform our plans for zervimesine in Alzheimer’s disease.”
Intrusion Inc. received a formal notification from Nasdaq granting an additional 180-day extension, until May 3, 2027, to regain compliance with the $1.00 minimum bid price requirement. The company failed to regain compliance during the initial 180-day period and has indicated it may implement a reverse stock split if necessary to cure the deficiency. The common stock will continue to trade on the Nasdaq Capital Market under the symbol 'INTZ' during this second compliance period.
Bio Green Med Solution Nasdaq/NYSE Compliance Notice
Bio Green Med Solution received a deficiency notice from Nasdaq on October 29, 2026, because its common stock failed to maintain a minimum bid price of $1.00 for 30 consecutive business days. The company has until April 27, 2027, to regain compliance and is considering a reverse stock split as a potential remedy in connection with its pending business combination with Future NRG Sdn. Bhd.
Cayson Acquisition Corp received a notice from Nasdaq on October 29, 2026, indicating that the company failed to regain compliance with the Minimum Total Holders Rule (Listing Rule 5450(a)(2)) during its extension period. Consequently, Nasdaq has initiated delisting procedures for the company's securities. The company has appealed the determination to maintain its listing while it works to provide documentation establishing the required 400 total holders.
Borealis Foods notified Nasdaq that it was briefly out of compliance with Listing Rule 5605(c)(2)(A) because its Audit Committee fell below the required three members following a director's committee resignation. The company regained compliance on October 29, 2026, by appointing Danat Shiderkulov to the Board and its committees, filling vacancies left by the resignation of Pavel Mynzhanov and the committee departures of Zaure Algaziyeva.
Bayview Acquisition Corp received notice that the Nasdaq board of directors declined to review a prior decision to delist the company's securities. Nasdaq will proceed with filing a Form 25-NSE to formally remove the company's units, ordinary shares, and rights from listing. The company is currently seeking to have its ordinary shares quoted on the OTC Pink Market.
Ribbon Acquisition Corp. received a deficiency notice from Nasdaq on October 30, 2026, for failing to maintain the minimum market value of listed securities (MVLS) of $35 million. The company has 180 calendar days, or until April 28, 2027, to regain compliance by maintaining an MVLS of at least $35 million for 10 consecutive business days.
Our Bond, Inc. has regained compliance with Nasdaq's minimum bid price requirement after its common stock maintained a closing bid price of at least $1.00 for ten consecutive business days. The company had previously been notified of its non-compliance on July 14, 2026.
House of Doge Inc. received a Staff Delisting Determination from Nasdaq on October 27, 2026, after its common stock closing bid price fell to $0.10 or less for ten consecutive trading days. Trading of the company's common stock (HODO) is scheduled to be suspended on November 3, 2026, unless the company successfully appeals the decision to a Nasdaq Hearings Panel. The company is evaluating its options, including a potential reverse stock split to regain compliance with the $1.00 minimum bid price requirement.
Cyngn Inc. notified Nasdaq that it will fall out of compliance with Audit Committee requirements following the resignation of director Karen Macleod on November 3, 2026. The company will have a cure period until its next annual meeting or November 3, 2027, to appoint a third independent director and regain compliance. Ms. Macleod's departure was not due to any disagreement with the company's operations or policies.
Annovis Bio received a deficiency notice from the NYSE for failing to maintain a minimum average market capitalization of $50 million and stockholders' equity of $50 million over a 30-day period. The company has 45 days to submit a compliance plan and 9 months to regain compliance to avoid delisting. During this period, the stock will continue to trade under the symbol 'ANVS' with an added '.BC' designation.
Alset Inc. received a deficiency notice from Nasdaq on October 28, 2026, because its common stock closing bid price remained below $1.00 for 30 consecutive trading days. The company has until April 26, 2027, to regain compliance and intends to resolve the deficiency, potentially through a previously announced 1-for-5 reverse stock split.
Accendra Health received a deficiency notice from the NYSE for failing to maintain an average market capitalization and stockholders' equity of at least $50.0 million. The company has 45 days to submit a business plan to regain compliance within 18 months and its stock will continue to trade on the exchange during this period.
Bridger Aerospace Group Holdings Nasdaq/NYSE Compliance Notice
Bridger Aerospace Group Holdings received a deficiency notice from Nasdaq on October 28, 2026, because its common stock failed to maintain a minimum bid price of $1.00 for 30 consecutive business days. The company has until April 26, 2027, to regain compliance by maintaining a closing bid price of at least $1.00 for ten consecutive business days. Management is monitoring the situation and may consider options such as a reverse stock split to resolve the deficiency.
Parabolic Technologies received a delisting determination from Nasdaq after failing to maintain a minimum bid price of $1.00 for 30 consecutive business days. Because the company has already effected cumulative reverse stock splits exceeding a 1-for-250 ratio in the past two years, it is ineligible for a standard 180-day compliance period and faces immediate delisting unless it successfully appeals to a Nasdaq Hearings Panel.
Actuate Therapeutics received a deficiency notice from Nasdaq because its common stock closed below the $1.00 minimum bid price for 30 consecutive business days. The company has until April 26, 2027, to regain compliance by maintaining a closing bid price of at least $1.00 for 10 consecutive business days. This notice follows a separate July 2026 warning regarding the company's failure to meet the minimum market value of listed securities requirement.
Neumora Therapeutics received a deficiency notice from Nasdaq for failing to maintain the $1.00 minimum bid price requirement for its common stock. The company has 180 calendar days, until April 26, 2027, to regain compliance by having its stock close at $1.00 or higher for at least ten consecutive business days.
Game Your Game Inc. received a deficiency notice from Nasdaq on October 27, 2026, because its common stock failed to maintain a minimum bid price of $1.00 per share for 30 consecutive business days. The company has 180 calendar days, until April 26, 2027, to regain compliance by maintaining a $1.00 closing bid price for at least 10 consecutive business days. Separately, the company appointed Veronica V. Montenegro as an independent director and chairperson of the nominating and corporate governance committee.
Armlogi Holding Corp. received a notification from Nasdaq confirming it has regained compliance with the $1.00 minimum bid price requirement for continued listing. The company's common stock maintained a closing bid price of at least $1.00 for 10 consecutive business days from October 15 to October 28, 2026.
Aldel Financial II Inc. received a delisting notice from Nasdaq on October 28, 2026, with trading of its securities expected to be suspended on November 6, 2026, due to failure to meet listing requirements. Separately, the company issued a $1.0 million unsecured promissory note to its sponsor, Aldel Investors II LLC, to fund working capital and trust account extension payments.
Propanc Biopharma received a delisting notice from Nasdaq on October 23, 2026, for failing to maintain the $1.00 minimum bid price requirement. Because the company already completed a reverse stock split within the past year, it is ineligible for the standard 180-day grace period and faces delisting on November 2, 2026. The company intends to appeal the determination to a hearings panel, which will stay the delisting process.